<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Oral antibiotic regimens for completing treatment of vertebral osteomyelitis in adults*</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Oral antibiotic regimens for completing treatment of vertebral osteomyelitis in adults*</h1>
<div class="graphic"><div class="figure"><div class="ttl">Oral antibiotic regimens for completing treatment of vertebral osteomyelitis in adults*</div><div class="cntnt"><table cellspacing="0"><colgroup span="3" width="33%"></colgroup> <tbody> <tr> <td class="subtitle1">Infectious agent</td> <td class="subtitle1">Antibiotic regimen<sup>¶</sup></td> <td class="subtitle1">Dosing</td> </tr> <tr> <td class="divider_bottom" rowspan="6"><strong>Staphylococci, methicillin susceptible</strong></td> <td colspan="2"><strong>One of the following:</strong></td> </tr> <tr> <td class="indent1"> <ul> <li>Rifampin<sup>Δ</sup> <strong>plus</strong> one of the following:</li> </ul> </td> <td>300 to 450 mg twice daily</td> </tr> <tr> <td class="indent2"> <ul style="list-style-type: disc;"> <li>Levofloxacin</li> </ul> </td> <td>500 to 750 mg once daily</td> </tr> <tr> <td class="indent2"> <ul style="list-style-type: disc;"> <li>Ciprofloxacin</li> </ul> </td> <td>500 to 750 mg twice daily</td> </tr> <tr> <td class="indent2"> <ul style="list-style-type: disc;"> <li>Fusidic acid (where available)<sup>◊</sup></li> </ul> </td> <td>500 mg three times daily</td> </tr> <tr class="divider_bottom"> <td class="indent1"> <ul> <li>Clindamycin</li> </ul> </td> <td>300 to 450 mg three times daily</td> </tr> <tr> <td class="divider_bottom" rowspan="7"><strong>Staphylococci, methicillin resistant</strong></td> <td colspan="2"><strong>One of the following:</strong></td> </tr> <tr> <td class="indent1"> <ul> <li>Rifampin<sup>Δ</sup> <strong>plus</strong> one of the following:</li> </ul> </td> <td>300 to 450 mg twice daily</td> </tr> <tr> <td class="indent2"> <ul style="list-style-type: disc;"> <li>Levofloxacin</li> </ul> </td> <td>500 to 750 mg once daily</td> </tr> <tr> <td class="indent2"> <ul style="list-style-type: disc;"> <li>Ciprofloxacin</li> </ul> </td> <td>500 to 750 mg twice daily</td> </tr> <tr> <td class="indent2"> <ul style="list-style-type: disc;"> <li>Fusidic acid (where available)<sup>◊</sup></li> </ul> </td> <td>500 mg three times daily</td> </tr> <tr> <td class="indent1"> <ul> <li>Clindamycin</li> </ul> </td> <td>300 to 450 mg three times daily</td> </tr> <tr class="divider_bottom"> <td class="indent1"> <ul> <li>Linezolid</li> </ul> </td> <td>600 mg twice daily</td> </tr> <tr> <td class="divider_bottom" rowspan="4"><strong>Gram-negative organisms</strong></td> <td colspan="2"><strong>One of the following:</strong></td> </tr> <tr> <td class="indent1"> <ul> <li>Ciprofloxacin<sup>§</sup></li> </ul> </td> <td>500 to 750 mg twice daily</td> </tr> <tr> <td class="indent1"> <ul> <li>Levofloxacin<sup>§</sup></li> </ul> </td> <td>500 to 750 mg once daily</td> </tr> <tr class="divider_bottom"> <td class="indent1"> <ul> <li>Trimethoprim-sulfamethoxazole</li> </ul> </td> <td>1 double-strength tablet twice daily</td> </tr> <tr> <td rowspan="3"><strong>Penicillin-sensitive streptococci</strong></td> <td colspan="2"><strong>One of the following:</strong></td> </tr> <tr> <td class="indent1"> <ul> <li>Amoxicillin<sup>¥</sup></li> </ul> </td> <td>750 to 1000 mg three times daily</td> </tr> <tr> <td class="indent1"> <ul> <li>Clindamycin</li> </ul> </td> <td>300 to 450 mg three times daily</td> </tr> </tbody></table></div><div class="graphic_lgnd">The doses recommended above are intended for adults with normal renal function; the doses of some of these agents must be adjusted in patients with renal insufficiency. Refer to the Lexicomp drug-specific monographs for renal dose adjustments.</div><div class="graphic_footnotes">* Following at least two weeks of parenteral therapy, completion of treatment with oral therapy may be reasonable in some circumstances; refer to UpToDate for further discussion.<br/>¶ The choice of antibiotic regimen should be based on susceptibility, as well as patient drug allergies, intolerances, and potential drug-drug interactions or contraindications to a specific agent.<br/>Δ Rifampin should not be used alone; it must be combined with a second agent to reduce the likelihood of selection for drug resistance.<br/><font class="lozenge">◊</font> Fusidic acid is not available in the United States. Fusidic acid should not be used alone; it must be combined with a second agent to reduce the likelihood of selection for drug resistance. When rifampicin is combined with fusidic acid, fusidic acid levels may be reduced.<sup>[1]</sup><br/>§ Ciprofloxacin and levofloxacin have activity against <em>Pseudomonas aeruginosa</em>. For <em>P. aeruginosa</em> the higher dose range of fluoroquinolone should be used; ciprofloxacin 750 mg every 12 hours or levofloxacin 750 mg once daily.<br/>¥ Oral amoxicillin therapy may be considered after an initial period of intravenous therapy for the management of penicillin-susceptible streptococci.</div><div class="graphic_reference">Reference:

<ol>
<li>Pushkin R, Iglesias-Ussel MD, Keedy K, et al. A randomized study evaluating oral fusidic acid (CEM-102) in combination with oral rifampin compared with standard-of-care antibiotics for treatment of prosthetic joint infections: a newly identified drug-drug interaction. Clin Infect Dis 2016; 63:1599.</li>
</ol>

Data from:

<ol>
<li>Société de Pathologie Infectieuse de Langue Français (SPILF). Primary infectious spondylitis and following intradiscal procedure, without prosthesis. Recommendations. Med Mal Infect 2007; 37:573.</li>
<li>Berbari EF, Kanj SS, Kowalski TJ, et al. 2015 Infectious Diseases Society of America (IDSA) clinical practice guidelines for the diagnosis and treatment of native vertebral osteomyelitis in adults. Clin Infect Dis 2015; 61:e26.</li>
<li>Bernard L, Dinh A, Ghour I, et al Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial. Lancet 2015; 385:875.</li>
<li>Li H-K, Rombach I, Zambellas R, Oral versus Intravenous Antibiotics for Bone and Joint Infection. NEJM 2019; 380:425.</li>
</ol></div><div id="graphicVersion">Graphic 126376 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
